Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.

Nancy U Lin; Wolfgang Eierman; Richard Greil; Mario Campone; Bella Kaufman; Klaudia Steplewski; Stephen R Lane; Denise Zembryki; Stephen D Rubin; Eric P Winer

doi:10.1007/s11060-011-0629-y

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.

Nancy U Lin
, Wolfgang Eierman
, Richard Greil (Co-Autor/-in)
, Mario Campone
, Bella Kaufman
, Klaudia Steplewski
, Stephen R Lane
, Denise Zembryki
, Stephen D Rubin
, Eric P Winer

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

125 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	613-620
Fachzeitschrift	JOURNAL OF NEURO-ONCOLOGY
Jahrgang	105
Ausgabenummer	3
DOIs	https://doi.org/10.1007/s11060-011-0629-y
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.1007/s11060-011-0629-y

Dieses zitieren

Lin, N. U., Eierman, W., Greil, R., Campone, M., Kaufman, B., Steplewski, K., Lane, S. R., Zembryki, D., Rubin, S. D., & Winer, E. P. (2011). Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. JOURNAL OF NEURO-ONCOLOGY , 105(3), 613-620. https://doi.org/10.1007/s11060-011-0629-y

Lin, Nancy U ; Eierman, Wolfgang ; Greil, Richard et al. / Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. in: JOURNAL OF NEURO-ONCOLOGY 2011 ; Jahrgang 105, Nr. 3. S. 613-620.

@article{5a23f687203b4d09aa7aef1eeb2b7600,

title = "Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.",

keywords = "NERVOUS-SYSTEM METASTASES, CEREBROSPINAL-FLUID, TRASTUZUMAB, SURVIVAL, THERAPY, COMBINATION, CARCINOMA, TUMORS, TRIAL",

author = "Lin, \{Nancy U\} and Wolfgang Eierman and Richard Greil and Mario Campone and Bella Kaufman and Klaudia Steplewski and Lane, \{Stephen R\} and Denise Zembryki and Rubin, \{Stephen D\} and Winer, \{Eric P\}",

note = "IIIrd Medical Department with Hematology and Medical Oncology, Private Medical University Hospital, Salzburg, Austria",

year = "2011",

doi = "10.1007/s11060-011-0629-y",

language = "English",

volume = "105",

pages = "613--620",

journal = "JOURNAL OF NEURO-ONCOLOGY ",

issn = "0167-594X",

publisher = "Springer Nature",

number = "3",

}

Lin, NU, Eierman, W, Greil, R, Campone, M, Kaufman, B, Steplewski, K, Lane, SR, Zembryki, D, Rubin, SD & Winer, EP 2011, 'Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.', JOURNAL OF NEURO-ONCOLOGY , Jg. 105, Nr. 3, S. 613-620. https://doi.org/10.1007/s11060-011-0629-y

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. / Lin, Nancy U; Eierman, Wolfgang; Greil, Richard (Co-Autor/-in) et al.
in: JOURNAL OF NEURO-ONCOLOGY , Jahrgang 105, Nr. 3, 2011, S. 613-620.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.

AU - Lin, Nancy U

AU - Eierman, Wolfgang

AU - Greil, Richard

AU - Campone, Mario

AU - Kaufman, Bella

AU - Steplewski, Klaudia

AU - Lane, Stephen R

AU - Zembryki, Denise

AU - Rubin, Stephen D

AU - Winer, Eric P

N1 - IIIrd Medical Department with Hematology and Medical Oncology, Private Medical University Hospital, Salzburg, Austria

PY - 2011

Y1 - 2011

KW - NERVOUS-SYSTEM METASTASES

KW - CEREBROSPINAL-FLUID

KW - TRASTUZUMAB

KW - SURVIVAL

KW - THERAPY

KW - COMBINATION

KW - CARCINOMA

KW - TUMORS

KW - TRIAL

U2 - 10.1007/s11060-011-0629-y

DO - 10.1007/s11060-011-0629-y

M3 - Original Article

C2 - 21706359

SN - 0167-594X

VL - 105

SP - 613

EP - 620

JO - JOURNAL OF NEURO-ONCOLOGY

JF - JOURNAL OF NEURO-ONCOLOGY

IS - 3

ER -

Lin NU, Eierman W, Greil R, Campone M, Kaufman B, Steplewski K et al. Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. JOURNAL OF NEURO-ONCOLOGY . 2011;105(3):613-620. doi: 10.1007/s11060-011-0629-y